The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...

The FDA has expanded the approval of Baqsimi nasal powder to include treatment of severe hypoglycemia in patients aged 1 year and older with diabetes.

“Continuous glucose monitors with low-glucose alerts can potentially reduce the risk of hypoglycemia for insulin-treated ...

Advertisement management junior Yashika Ramchandani created T100 Pro Bars, power bars geared towards people with diabetes and ...

The following is a summary of “Efficacy and Hypoglycemia Profile of Once-Weekly Insulin Icodec vs. Once-Daily Comparators ...

The Food and Drug Administration (FDA) has expanded the approval of Baqsimi (glucagon) nasal powder to include the treatment of severe hypoglycemia in patients aged 1 year and older with diabetes.

Insulet Corporation’s RADIANT study shows glycaemic improvements with Omnipod 5 automated insulin delivery system: Action, Massachusetts Friday, March 21, 2025, 18:00 Hrs [IST] ...

Data from the Barbara Davis Center for Diabetes at University of Colorado show pilots with type 1 diabetes are not just ...

A thorough review of 21 cases involving acutely ill children associated with these products raises concerns. Researchers ...

Tandem Diabetes Care (Nasdaq:TNDM) today announced positive data supporting its automated insulin delivery technology for ...

The Day of Service is hosted by the Lions Clubs of Cottage Grove, Hastings Rivertown, South St. Paul, St. Paul Park, Newport ...